Iovance Biotherapeutics
IOVA
#5408
Rank
A$1.62 B
Marketcap
$4.96
Share price
-7.69%
Change (1 day)
-75.87%
Change (1 year)

Earnings for Iovance Biotherapeutics (IOVA)

Earnings in 2024 (TTM): -A$0.61 Billion

According to Iovance Biotherapeutics 's latest financial reports the company's current earnings are A$0.16 Billion. , an increase over its 2023 earnings that were of -A$0.77 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Iovance Biotherapeutics from 2008 to 2024

Annual earnings

Year Earnings Change
2024 -A$0.66 Billion-14.17%
2023 -A$0.77 Billion15.46%
2022 -A$0.66 Billion16.39%
2021 -A$0.57 Billion30.83%
2020 -A$0.44 Billion26.62%
2019 -A$0.35 Billion61.29%
2018 -A$0.22 Billion38.09%
2017 -A$0.16 Billion73.16%
2016 -A$88.72 Million92.7%
2015 -A$46.04 Million131.17%
2014 -A$19.92 Million-51.71%
2013 -A$41.25 Million6291.81%
2012 -A$0.65 Million
2008 -A$0.1 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$58.35 M-108.93%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$3.58 Million-99.45% Bahamas